Mastercard Incorporated First-Quarter 2018 Financial Results Available on Company’s Website

PURCHASE, N.Y.--(BUSINESS WIRE)-- Mastercard Incorporated (NYSE: MA) today announced its financial results for its first quarter of 2018 through an earnings release available on the company’s Investor Relations website at www.mastercard.com/investor. The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and available here.

At 9:00 a.m. ET today, the company will host a conference call to discuss these financial results. The dial-in information for this call is 833-236-5755 (within the U.S.) and 647-689-4183 (outside the U.S.). A replay of the call will be available for 30 days and can be accessed by dialing 800-585-8367 (within the U.S.) and 416-621-4642 (outside the U.S.), using passcode 5073027.

This call and all related materials can also be accessed through the Mastercard Investor Relations website at http://investor.mastercard.com/investor-relations/events-and-presentations/default.aspx.

About Mastercard Incorporated

Mastercard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. Our global payments processing network connects consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities - such as shopping, traveling, running a business and managing finances - easier, more secure and more efficient for everyone. Follow us on Twitter @MastercardNews, join the discussion on the Beyond the Transaction Blog and subscribe for the latest news on the Engagement Bureau.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180502005791/en/

Investor Relations:
Warren Kneeshaw or Gina Accordino, 914-249-4565
[email protected]
or
Media Relations:
Seth Eisen, 914-249-3153
[email protected]

Source: Mastercard Investor Relations

You May Also Be Interested In

• Farmmi announces public offering of Class A ordinary shares
• Cosmos Health signs Qatar distribution deal, gets 31,000-unit order
• FDA approves Viridian's Lumvoa for thyroid eye disease